Dr. Studts enjoyed a productive and rewarding research, mentoring and service year in 2018. With regard to his research efforts, Dr. Studts continued to serve as the principal investigator of the Kentucky LEADS Collaborative, a multi-level, interdisciplinary project dedicated to developing and evaluating novel provider education, survivorship care, and prevention and early detection interventions to reduce reducing the burden of lung cancer in Kentucky. Dr. Studts also initiated work on several newly-funded grants addressing aspects of lung cancer prevention and control with support from the Bristol Myers-Squibb Foundation and the Kentucky Lung Cancer Research Program. Dr. Studts continued his work with Health Decision Technologies to study a novel point-of-care software package to promote implementation of evidence-based tobacco cessation strategies in dental care settings and on a NIDA funded grant to Dr. Hannah Knudsen exploring implementation and provider decision making regarding buprenorphine. Dr. Studts also continued funded collaborations with Dr. Vanderpool on the LAUNCH project, leveraging technology to improve rural lung cancer outcomes and with Dr. Burris on Markey CARES, supporting implementation of evidence-based tobacco treatments in oncology settings. Both projects are supported by the National Cancer Institute. In collaboration with Drs. Valentino and C. Studts, Dr. Studts co-leads a clinical trial examining the impact of evidence-based tobacco cessation interventions among individuals recently diagnosed with lung or head/neck cancer, funded by a grant from the Kentucky Lung Cancer Research Program and supported by the Kentucky Clinical Trials Network. In collaboration with colleagues at West Virginia University, Dr. Studts completed a study funded by the NCI to study a novel intervention to communicate risk of breast cancer recurrence following treatment for breast cancer as well as studies funded by Owensboro Health and the Nieman Policy Institute regarding implementation of lung cancer screening. Dr. Studts published 5 peer-reviewed academic papers in 2018, and he delivered 17 invited talks (locally, regionally, nationally, and internationally) and 9 conference presentations. In the teaching/mentoring domain, Dr. Studts continues to serve as the primary mentor for Dr. Burris’ NCI career development grant and four other junior faculty. Dr. Studts also mentored 1 medical student, 1 graduate student, 1 undergraduate student, and 1 high school student in addition to serving on multiple graduate committees. With regard to academic and scientific service, Dr. Studts chaired the Quality of Life study section for the Canadian Cancer Society Research Institute and served as a panel member for the Cancer Prevention Research Institute of Texas, the Kentucky Lung Cancer Research Program, the Markey Cancer Center Pilot Program, and the Markey ACS-IRG. He reviewed 11 manuscripts for scientific journals and abstracts for 4 academic conferences, and he served on the editorial board for the journals Medical Decision Making, Journal of Behavioral Medicine, Medical Decision Making: Policy & Practice, and The Patient. Dr. Studts continued to serve as the Assistant Director of Cancer Prevention and Control and the Director of the Behavioral and Community-Based Research Shared Resource Facility for the Markey Cancer Center. Dr. Studts also serves as a member of the Markey Cancer Center Membership Committee and the Protocol Review and Monitoring Committee. Within the Department of Behavioral Science, Dr. Studts served as a member of the Admissions Committee and the Curriculum Committee. Outside the Department, Dr. Studts served on faculty search committees for the Department of Communication, the Markey Cancer Center, and the Center for Health Equity Transformation. Finally, Dr. Studts served as a member of the Steering Committee for the UK Center for Health Services Research and a member of the UK Senate Advisory Committee on Faculty Code. Most recently, Dr. Studts has been appointed the Director of Team Science for the University of Kentucky Center for Clinical and Translational Science. On the state level, Dr. Studts co-leads the Kentucky Lung Cancer Network of the Kentucky Cancer Consortium and continues to serve on its Survivorship Working Group, the Affordable Care Act and the Radon Action subcommittees. Nationally, Dr. Studts continued to serve on the Medical and Professional Advisory Board of the Lung Cancer Alliance and the Shared Decision Making and Provider Engagement Working Groups of the National Lung Cancer Roundtable organized by the American Cancer Society. Most recently, Dr. Studts agreed to serve as the Chair of the National Lung Cancer Roundtable’s Survivorship, Stigma, and Nihilism Task Group.
Principal Investigator,“Attitudes and Beliefs regarding Nicotine Vaccines as Treatment and Prophylaxis for Nicotine Dependence,” Kentucky Lung Cancer Research Program (2006-2008).
Co-Investigator, “Telehealth Symptom Management in Head and Neck Cancer,” National Cancer Institute (2005-2007).
Principal Investigator, “Adjuvant Treatment Decision Making for Lung Cancer,” National Cancer Institute (2005-2008).
Principal Investigator, “Behavioral, Cognitive, and Affective Responses to Lung Cancer Screening,” Kentucky Lung Cancer Research Program (2003-2008).
Principal Investigator, “Behavioral Oncology Clinic – Breast Program,” Susan G. Komen Breast Cancer Foundation – Louisville Affiliate (2003-2007).
Co-Investigator, “Cancer as a Chronic Disease,” Centers for Disease Control & Prevention (2005-2006)
Studts, J. L., Matera, E. L., Worth, C. T., Ghate, S. R., Miller, B. F., Thomas, S. D., & Sorrell, C. L. (In press). Tobacco cessation treatment knowledge, attitudes and practices of Kentucky physicians. Journal of the Kentucky Medical Association.
Studts, J. L., Ghate, S. R., Marmorato, J. L., Studts, C. R., Barnes, C. N., LaJoie, A. S., Andrykowski, M. A., & LaRocca, R. V. (2006). Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiology, Biomarkers and Prevention, 15, 1825-1828.
Chagpar, A. B., Studts, J. L., Scoggins, C. R., Martin, R. C. G., Carlson, D. J., Laidley, A. L., El-Eid, S. E., McGlothin, T. E., Noyes, R. D., & McMasters, K. M. (2006). Factors associated with breast cancer surgical options. Cancer, 106, 1462-1466.
Martin, R. C. G., McGuffin, S. A., Roetzer, L. M., Abell, T. D., & Studts, J. L. (2006). Method of presenting oncology treatment outcomes influences patient treatment decision-making in metastatic colorectal cancer. Annals of Surgical Oncology, 13, 86-95.
Studts, J. L., Abell, T. D., Roetzer, L. M., Albers, A. N., McMasters, K. M., & Chao, C. (2005). Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer. Psycho-oncology, 14, 647-660.
Chao, C., Studts, J. L., Abell, T., Hadley, T., Roetzer, L., Dineen, S., Lorenz, D., YoussefAgha, A., McMasters, K. M. (2003). Adjuvant chemotherapy for breast cancer: How presentation of recurrence risk influences decision-making. Journal of Clinical Oncology, 21, 4299-4305.